Literature DB >> 9223458

Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease.

N Sheng1, S C Pettit, R J Tritch, D H Ozturk, M M Rayner, R Swanstrom, S Erickson-Viitanen.   

Abstract

During human immunodeficiency virus type 1 (HIV-1) virion assembly, cleavage of the Gag precursor by the viral protease results in the transient appearance of a nucleocapsid-p1-p6 intermediate product designated p15NC. Utilizing the p15NC precursor protein produced with an in vitro transcription-translation system or purified after expression in Escherichia coli, we have demonstrated that RNA is required for efficient cleavage of HIV p15NC. Gel mobility shift and nitrocellulose filter binding experiments indicate that purified p15NC protein specifically binds its corresponding mRNA with an estimated Kd of 1.5 nM. Binding was not affected by the presence or absence of zinc or EDTA. Moreover, mutagenesis of the cysteine residues within either of the two Cys-His arrays had no effect on RNA binding or on RNA-dependent cleavage by the viral protease. In contrast, decreased binding of RNA and diminished susceptibility to cleavage in vitro were observed with p15NC-containing mutations in one or more residues within the triplet of basic amino acids present in the region between the two zinc fingers. In addition, we found that 21- to 24-base DNA and RNA oligonucleotides of a particular sequence and secondary structure could substitute for p15 RNA in the enhancement of p15NC cleavage. Virus particles carrying a mutation in the triplet of NC basic residues (P3BE) show delayed cleavage of p15NC and a defect in core formation despite the eventual appearance of fully processed virion protein. These results define determinants of the p15NC-RNA interaction that lead to enhanced protease-mediated cleavage and demonstrate the importance of the triplet of basic residues in formation of the virus core.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223458      PMCID: PMC191824     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Formation of stable and functional HIV-1 nucleoprotein complexes in vitro.

Authors:  V Tanchou; C Gabus; V Rogemond; J L Darlix
Journal:  J Mol Biol       Date:  1995-10-06       Impact factor: 5.469

2.  Analysis of human immunodeficiency virus type 1 protease activity in eukaryotic and bacterial cells.

Authors:  A H Kaplan; M Manchester; L Everitt; R Swanstrom
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

3.  Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo.

Authors:  R D Berkowitz; A Ohagen; S Höglund; S P Goff
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

4.  Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity.

Authors:  F Dib-Hajj; R Khan; D P Giedroc
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

5.  Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein.

Authors:  N E Bowles; P Damay; P F Spahr
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

6.  Zinc- and sequence-dependent binding to nucleic acids by the N-terminal zinc finger of the HIV-1 nucleocapsid protein: NMR structure of the complex with the Psi-site analog, dACGCC.

Authors:  T L South; M F Summers
Journal:  Protein Sci       Date:  1993-01       Impact factor: 6.725

7.  Conformational and nucleic acid binding studies on the synthetic nucleocapsid protein of HIV-1.

Authors:  A Surovoy; J Dannull; K Moelling; G Jung
Journal:  J Mol Biol       Date:  1993-01-05       Impact factor: 5.469

8.  RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.

Authors:  J Clever; C Sassetti; T G Parslow
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.

Authors:  Y Zhang; E Barklis
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.

Authors:  H G Kräusslich; M Fäcke; A M Heuser; J Konvalinka; H Zentgraf
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  31 in total

Review 1.  Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Robert J Gorelick
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

2.  Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.

Authors:  A Cimarelli; S Sandin; S Höglund; J Luban
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 3.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

4.  Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.

Authors:  Ying-Chuan Lin; Ashraf Brik; Aymeric de Parseval; Karen Tam; Bruce E Torbett; Chi-Huey Wong; John H Elder
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 5.  The choreography of HIV-1 proteolytic processing and virion assembly.

Authors:  Sook-Kyung Lee; Marc Potempa; Ronald Swanstrom
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

6.  Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.

Authors:  Sook-Kyung Lee; Marc Potempa; Madhavi Kolli; Ayşegül Özen; Celia A Schiffer; Ronald Swanstrom
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

7.  Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.

Authors:  Steve C Pettit; Gavin J Henderson; Celia A Schiffer; Ronald Swanstrom
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

9.  Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions.

Authors:  D A Davis; K Yusa; L A Gillim; F M Newcomb; H Mitsuya; R Yarchoan
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA.

Authors:  Cameron P Keating; Melissa K Hill; David J Hawkes; Redmond P Smyth; Catherine Isel; Shu-Yun Le; Ann C Palmenberg; John A Marshall; Roland Marquet; Gary J Nabel; Johnson Mak
Journal:  Nucleic Acids Res       Date:  2008-12-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.